SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-06-10 12:52
Tx date 2025-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options
+2,645 vol 		2,645
Filed 2025-06-10 12:51
Tx date 2014-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2025-06-10 12:50
Tx date 2025-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+17,012 vol 		122,529
Filed 2024-12-18 19:45
Tx date 2024-11-22 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+4,891 vol 		28,464
Filed 2024-12-18 19:41
Tx date 2024-11-22 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-3,086 vol 		105,517
Filed 2024-12-18 19:39
Tx date 2024-11-22 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-3,500 vol 		108,603
Filed 2024-12-18 19:15
Tx date 2024-11-22 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-83,742
-2,040 vol
$41.05 each 		23,573
Filed 2024-12-18 19:14
Tx date 2024-11-22 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-41,630.80
-1,046 vol
$39.80 each 		25,613
Filed 2024-12-18 19:12
Tx date 2024-11-22 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$41,599
+3,086 vol
$13.48 each 		26,659
Filed 2024-12-18 19:10
Tx date 2024-11-22 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-117,204.61
-2,851 vol
$41.11 each 		23,573
Filed 2024-12-18 17:32
Tx date 2024-11-22 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
97 - Other 		$-25,830.20
-649 vol
$39.80 each 		26,424
Filed 2024-12-18 17:27
Tx date 2024-11-22 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$25,830
+3,500 vol
$7.38 each 		27,073
Filed 2024-06-07 14:46
Tx date 2024-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$593,082
+15,542 vol
$38.16 each 		112,103
Filed 2023-12-18 15:46
Tx date 2023-12-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-311,897.90
-7,598 vol
$41.05 each 		4,902
Filed 2023-12-18 15:41
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-158,443.68
-3,977 vol
$39.84 each 		23,573
Filed 2023-12-18 15:39
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$35,793
+3,977 vol
$9.00 each 		27,550
Filed 2023-12-18 15:35
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-12,580.26
-1,167 vol
$10.78 each 		96,561
Filed 2023-12-18 15:33
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-42,872.06
-3,977 vol
$10.78 each 		97,728
Filed 2023-12-18 15:29
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-90,047.30
-2,303 vol
$39.10 each 		23,573
Filed 2023-12-18 15:28
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$24,826
+2,303 vol
$10.78 each 		25,876
Filed 2023-12-18 15:27
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-22,895.36
-577 vol
$39.68 each 		101,705
Filed 2023-12-18 15:24
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-24,826.34
-2,303 vol
$10.78 each 		102,282
Filed 2023-12-18 15:19
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-198,594
-5,100 vol
$38.94 each 		23,573
Filed 2023-12-18 15:12
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$54,978
+5,100 vol
$10.78 each 		28,673
Filed 2023-12-18 15:06
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-13,776.84
-1,278 vol
$10.78 each 		104,585
Filed 2023-12-18 14:54
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-54,978
-5,100 vol
$10.78 each 		105,863
Filed 2023-06-05 13:28
Tx date 2023-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$719,786
+18,475 vol
$38.96 each 		110,963
Filed 2022-11-28 20:53
Tx date 2022-11-25 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-67,390.3607
-1,937 vol
$34.79 each 		23,573
Filed 2022-11-28 20:52
Tx date 2022-11-25 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-120 vol 		25,510
Filed 2022-11-28 20:51
Tx date 2022-11-25 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$5,512
+2,057 vol
$2.68 each 		25,630
Filed 2022-11-28 20:49
Tx date 2022-11-25 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-5,512.76
-2,057 vol
$2.68 each 		92,488
Filed 2022-11-28 20:46
Tx date 2022-11-23 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-70,609.6105
-2,057 vol
$34.33 each 		23,573
Filed 2022-06-29 18:53
Tx date 2022-06-28 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$541,980
+18,000 vol
$30.11 each 		94,545
Filed 2021-12-10 16:39
Tx date 2021-12-08 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,693
+2,057 vol
$3.74 each 		25,630
Filed 2021-12-10 16:36
Tx date 2021-12-08 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,693.18
-2,057 vol
$3.74 each 		76,545
Filed 2021-06-09 19:31
Tx date 2021-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: David Patou (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership
-100 vol 		0
Filed 2021-06-09 13:51
Tx date 2021-03-17 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: David Patou (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$1,948
+100 vol
$19.49 each 		100
Filed 2021-06-09 13:43
Tx date 2014-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: David Patou (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-04 19:55
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$185,600
+10,000 vol
$18.56 each 		78,602
Filed 2020-10-29 16:48
Tx date 2020-10-28 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,693
+2,057 vol
$3.74 each 		23,573
Filed 2020-10-29 16:46
Tx date 2020-10-28 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,693.18
-2,057 vol
$3.74 each 		68,602
Filed 2020-06-02 20:03
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		70,659
Filed 2019-12-06 17:25
Tx date 2019-12-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,693.18
-2,057 vol
$3.74 each 		60,659
Filed 2019-12-06 17:23
Tx date 2019-12-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,693
+2,057 vol
$3.74 each 		21,516
Filed 2019-09-19 14:50
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		62,716
Filed 2018-12-18
Tx date 2018-12-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,693
+2,057 vol
$3.74 each 		19,459
Filed 2018-12-18
Tx date 2018-12-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,693.18
-2,057 vol
$3.74 each 		47,716
Filed 2018-06-15
Tx date 2018-06-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$20,098
+5,374 vol
$3.74 each 		17,402
Filed 2018-06-15
Tx date 2018-06-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-2,856 vol 		49,773
Filed 2018-06-15
Tx date 2018-06-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-5,374 vol 		52,629
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		58,003
Filed 2018-01-04
Tx date 2018-01-01 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-3,497 vol 		43,003
Filed 2017-08-14
Tx date 2017-08-10 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$20,835
+7,500 vol
$2.78 each 		12,500
Filed 2017-08-10
Tx date 2014-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-10
Tx date 2017-08-08 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$15,002
+5,000 vol
$3.00 each 		5,000
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		46,500
Filed 2016-12-08
Tx date 2016-12-06 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$29,703
+7,942 vol
$3.74 each 		12,028
Filed 2016-12-08
Tx date 2016-12-06 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-46,170.30
-12,345 vol
$3.74 each 		43,000
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$25,830
+3,500 vol
$7.38 each 		55,345
Filed 2015-11-06
Tx date 2015-11-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$9,359
+1,542 vol
$6.07 each 		4,086
Filed 2015-11-06
Tx date 2015-11-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-21,226.79
-3,497 vol
$6.07 each 		51,845
Filed 2015-05-08
Tx date 2015-01-07 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$15,442
+2,544 vol
$6.07 each 		2,544
Filed 2015-05-08
Tx date 2015-01-07 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$21,226
+3,497 vol
$6.07 each
Filed 2015-05-07
Tx date 2015-05-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+3,086 vol 		55,342